Cardiometabolic Improvements Weight loss was accompanied by clinically meaningful improvements across several cardiovascular risk markers, including reductions in: Waist circumference (mean reduction of approximately 24.1 cm at the highest dose) Non-HDL cholesterol Triglycerides Systolic blood pressure High-sensitivity C-reactive protein (hsCRP) a marker of inflammation These findings are particularly relevant for patients with obesity who also live with cardiometabolic conditions, where systemic risk reduction is as important as the weight loss itself
A vendor that hides its lot numbers or its testing lab has not earned the trust of peers
Individuals seeking direct glutathione supplementation for antioxidative status, detoxification, cellular and immune health, and healthy aging.* Practitioner Reference L-Glutathione Power is positioned within the Designs for Health Foundational Health category
Crucially, hepatotoxicity, gastrointestinal upset and potential warfarin- and chemotherapeutic-drug interactions have been reported in rare cases of dosing concentrated green tea at pharmacological levels
Unified Vascular Response The unified vascular response across organ systems stems from BPC-157s activation of VEGFR2-Akt-eNOS and Src-Caveolin-1-eNOS signaling pathways, promoting angiogenesis and NO-dependent vasomodulation